
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.00 | 100.00 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.48 | 19.14 |
Price to Book | 3.33 | 4.34 |
Price to Sales | 2.42 | 2.43 |
Price to Cash Flow | 13.80 | 16.71 |
Dividend Yield | 1.72 | 1.13 |
5 Years Earnings Growth | 10.25 | 12.17 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.46 | 99.62 |
Financial Services | 1.97 | 0.63 |
Communication Services | 0.73 | 0.71 |
Consumer Defensive | 0.64 | 0.44 |
Basic Materials | 0.15 | 1.02 |
Technology | 0.05 | 0.16 |
Number of long holdings: 108
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.93 | 724.95 | -2.95% | |
UnitedHealth | US91324P1021 | 5.67 | 302.98 | -5.78% | |
Boston Scientific | US1011371077 | 5.46 | 104.64 | -1.78% | |
Regeneron Pharma | US75886F1075 | 4.24 | 604.62 | -1.65% | |
Pfizer | US7170811035 | 4.13 | 23.04 | -2.04% | |
Merck&Co | US58933Y1055 | 4.09 | 76.98 | -1.27% | |
Elevance Health | US0367521038 | 3.90 | 400.12 | -3.00% | |
AbbVie | US00287Y1091 | 3.88 | 181.80 | -1.65% | |
Chugai Pharmaceutical | JP3519400000 | 3.74 | 7,531.0 | +2.18% | |
Amgen | US0311621009 | 3.55 | 271.34 | -1.33% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Delaware Small Cap Core I | 5.36B | -11.48 | 2.70 | 7.09 | ||
Delaware Emerging Markets Instl | 2.85B | 3.39 | 4.53 | 4.81 | ||
Delaware Small Cap Value Instl | 2.31B | -8.70 | 2.70 | 6.49 | ||
Optimum Large Cap Growth Instl | 1.88B | -9.37 | 13.76 | 12.04 | ||
Optimum Large Cap Value Instl | 1.82B | -1.08 | 7.87 | 7.89 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review